Enquête de l'IUPHAR Early Career Researcher (ECR)

Dear Colleagues & Postgraduate Students,

The ‘Lessons from the COVID-19 pandemic for advancing pharmacological research for Early Career Researchers’ Survey launched recently. This survey has been organised by the IUPHAR Early Career Researcher (ECR) Committee to identify issues facing ECRs with an interest in Pharmacology worldwide during the COVID-19 Pandemic.

This single survey is intended for ECRs including postgraduate students (Masters, PhD students both non-clinical & clinical), Research Staffs (Research assistants, technicians, postdocs, research fellows, early career researchers) and New Starting Investigators & Lecturers (Academic and Non-Academic staff).

Please fill in this form to help us collect information about the ECR research community, informing us about areas where you feel well recognised and supported, and helping us identifying areas where more support is needed during the Covid-19 pandemic. It should only take about 10 minutes to complete.

All data will be handled confidentially, with each individuals unidentified. Data will be analysed by the IUPHAR ECR Committee. Results from the survey will be reported & discussed with the IUPHAR Executive Committee and further published online. Thank you very much for your time.

Survey Link:
https://forms.gle/BU9TPUTcDXD94rbh9

If you have any questions or want to get in touch with the IUPHAR ECR Committee, please email us at admin@iuphar.org.

  • Dernière mise à jour le .

SIF : 2 Research awards for works on Pharmadvances

Voici une communication de la Société Italienne de Pharmacologie (SIF) qui  propose 2 prix de recharches. La SFPT est affiliée à l'Ephar, nos membres peuvent donc postuler ... Profitez-en !

To EPHAR member societies.

The Italian Society of Pharmacology confers n.2 Research Awards of € 500.00 (five hundred/00) gross each to PhD Students, Fellow, Post Doc and Specialist Trainees members of national society member of EACPT, EPHAR and IUPHAR who published as single author, by March 2022, a work on Pharmadvances having as subject their PhD thesis introduction.

Pharmadvances (http://www.pharmadvances.com/) is the SIF’s English language Journal devoted to an international audience of pharmacologists and clinicians. The Journal aims to expand the horizon of this scientific discipline and to encourage high-quality international research.

Application instructions and forms are available at the following link:

SIF- Borse di ricerca

  • Dernière mise à jour le .

Nouveau bulletin addictovigilance : enquête ASOS (Antalgiques Stupéfiants et Ordonnances Sécurisées)

Le dernier bulletin national d’Addictovigilance vient de paraître.

doigt il est disponible ici (ou en cliquant sur l'aperçu ci-dessous)

Ce bulletin  est consacré à l’enquête ASOS (Antalgiques Stupéfiants et Ordonnances Sécurisées), un des dispositifs développés par le réseau français d’Addictovigilance pour évaluer le bon usage des Antalgiques Stupéfiants. Les objectifs sont de décrire la population traitée par antalgiques stupéfiants et les modalités de leur prescription, d’évaluer le respect des règles de prescription et de suivre l’évolution dans le temps de ces données.
Ce bulletin présente les résultats de l’enquête ASOS en 2019 et l’évolution depuis 13 ans (2007-2019) de la morphine, l’oxycodone, le fentanyl, Hydromorphone, Buprénorphine (hors MSO), Tapentadol

Ce bulletin inaugure le tout nouveau site du réseau Français d’Addictovigilance :
https://addictovigilance.fr

Vous pourrez y trouver également l’ensemble de ces bulletins en accès libre (notamment ceux sur les décès aux produits, le tramadol, le cannabidiol) ainsi que des capsules sur les missions et les activités des pharmacologues du Réseau Français d’Addictovigilance :
https://addictovigilance.fr/medias/

BullteinAddictoJuin2021

  • Dernière mise à jour le .

Important News from IUPHAR about WCP2022

 

Dear IUPHAR Colleague,

You may have already heard some important news about the 19th World Congress of Basic and Clinical Pharmacology. After consultation between the International Union of Basic and Clinical Pharmacology (IUPHAR) and the British Pharmacological Society, we have decided to move the congress from 2022 to 2-7 July 2023. We are determined that there should be as few barriers as possible to delegates attending and joining us in Glasgow. At the heart of our decision is the safety and wellbeing of everyone involved, as well as accessibility. Several countries around the world have begun to implement vaccination programmes to tackle the spread of COVID-19, and ultimately to bring the pandemic to an end.

However, because of the variation in vaccination schemes across different countries and the possibility that without vaccination travel may not be possible, we are concerned that holding the congress in 2022 may mean that some delegates cannot attend. In addition, across the globe there are also varying travel and quarantine restrictions between countries, and there is some considerable uncertainty regarding the availability of airline carriers and other international transport.

In addition, the move creates more time for those who have been hampered by increased or changing workloads due to the pandemic, to participate and contribute fully.

We hope you will agree that moving WCP to 2023 is a positive step and one which will ensure we can meet safely face-to-face when global vaccination is on a surer footing, for a vibrant and celebratory congress.

Please update your diaries with the new dates, and we will be in touch soon with further news and updates.

                                      Watch now: WCP 2023 Announcement - Professor Amrita Ahluwalia

 

                                                                

  • Dernière mise à jour le .

Conception Internet Bordeaux LOGO internet bordeaux mini - Webmaster Vincent RICHARD